Find research datasets worth reusing
Search datasets from major research repositories and use ShareScore to quickly assess how well each record supports discovery, access, and reuse.
2,854
datasets available to search
ShareScore release 0.9.0
Dataset results
2,854 results for “hepatocellular carcinoma”
A Study to Compare the Efficacy, Safety, Immunogenicity, and Pharmacokinetic Profile of HLX13 with YERVOY As a First-Line Treatment for Patients with Unresectable Hepatocellular Carcinoma
ClinicalTrials.gov study NCT06841185. IPD Sharing: NO. Countries: 0. Publications: 0.
An Exploratory Clinical Study on Neoadjuvant Treatment of Hepatocellular Carcinoma with QL1706 Combined with Lenvatinib
ClinicalTrials.gov study NCT06884982. IPD Sharing: NO. Countries: 0. Publications: 0.
The Study of Apatinib Plus Radiotherapy vs. Apatinib in the Treatment of Hepatocellular Carcinoma With BCLC-C Stage I and Stage II Portal Vein Tumor Thrombus
ClinicalTrials.gov study NCT03520257. IPD Sharing: UNDECIDED. Countries: 0. Publications: 0.
Liver Transplant for Larger Hepatocellular Carcinoma in Malatya: The Role of GGT and AFP
ClinicalTrials.gov study NCT04412161. IPD Sharing: UNDECIDED. Countries: 0. Publications: 0.
Transarterial Chemoembolization With Low-Dose Bevacizumab Plus Atezolizumab as First-Line Treatment for Unresectable Hepatocellular Carcinoma
ClinicalTrials.gov study NCT07281664. IPD Sharing: NO. Countries: 0. Publications: 0.
A Prospective Observational Cohort Study on Dynamic CD8+ T-cell Profiling and Multi-omics Biomarkers for Predicting Conversion Therapy Response in Unresectable Hepatocellular Carcinoma
ClinicalTrials.gov study NCT07117279. IPD Sharing: Not stated. Countries: 0. Publications: 0.
A Phase III Randomized Study of TACE Plus an Oral Triple-Agent Cocktail Versus TACE Plus First-Line Targeted Immunotherapy in Unresectable Hepatocellular Carcinoma
ClinicalTrials.gov study NCT07309419. IPD Sharing: NO. Countries: 0. Publications: 0.
PD-1/PD-L1 Inhibitors and Anti-angiogenic Therapy Combined With/Without TACE/HAIC in Patients With BCLC B/C Hepatocellular Carcinoma Beyond Up-to-7
ClinicalTrials.gov study NCT06423144. IPD Sharing: UNDECIDED. Countries: 0. Publications: 0.
Immunomonitoring of Interventional Radiology Procedures in the Management of Hepatocellular Carcinoma
ClinicalTrials.gov study NCT04892810. IPD Sharing: Not stated. Countries: 0. Publications: 0.
TAF Monotherapy Versus ETV Combined With TAF on the Efficacy and Prognosis of Immunotherapy for Hepatitis B-Related Hepatocellular Carcinoma
ClinicalTrials.gov study NCT07253220. IPD Sharing: NO. Countries: 0. Publications: 0.
A Clinical Study to Observe the Effectiveness and Safety of IBI310, Bevacizumab Combined With Sintilimab in the Treatment of Advanced Hepatocellular Carcinoma
ClinicalTrials.gov study NCT05363722. IPD Sharing: Not stated. Countries: 0. Publications: 0.
Selective Internal Radiation Therapy (SIRT) Versus Transarterial Chemoembolisation (TACE) for the Treatment of Hepatocellular Carcinoma (HCC).
ClinicalTrials.gov study NCT01798160. IPD Sharing: Not stated. Countries: 0. Publications: 0.
Radiotherapy Combined With QL1706 and Bevacizumab for Unresectable Non-metastatic Hepatocellular Carcinoma
ClinicalTrials.gov study NCT07179900. IPD Sharing: NO. Countries: 0. Publications: 0.
the Effect of Different Oxaliplatin Dose in Transarterial Infusion (TAI) in Unresectable Hepatocellular Carcinoma
ClinicalTrials.gov study NCT03777475. IPD Sharing: UNDECIDED. Countries: 1. Publications: 0.
Assessment of AFP and PIVKA-II as Prognostic Indicators in Liver Transplantation for Hepatocellular Carcinoma
ClinicalTrials.gov study NCT06331260. IPD Sharing: Not stated. Countries: 0. Publications: 0.
Transient Elastography in Hepatectomy for Hepatocellular Carcinoma
ClinicalTrials.gov study NCT01441453. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Iparomlimab and Tuvonralimab Injection (QL1706) Combined With Bevacizumab for Postoperative Adjuvant Therapy in Hepatocellular Carcinoma (HCC) With High Risk of Recurrence
ClinicalTrials.gov study NCT06958484. IPD Sharing: NO. Countries: 0. Publications: 0.
CT Volume Measurement of Hepatocellular Carcinoma
ClinicalTrials.gov study NCT07183566. IPD Sharing: UNDECIDED. Countries: 0. Publications: 0.
Treatment of Hepatocellular Carcinoma With Tetrathiomolybdate
ClinicalTrials.gov study NCT00006332. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Association Between Pre-op Non-Selective Beta-Blockers and Hepatocellular Carcinoma Recurrence Post-Liver Transplant
ClinicalTrials.gov study NCT06233708. IPD Sharing: NO. Countries: 0. Publications: 0.
ScienceDex guides
Understand access before you commit
These curated guides explain access requirements, typical timelines, costs, and reuse considerations for widely used research datasets.
Allen Brain Atlas
Allen Brain Atlas is an Allen Institute collection of brain map atlases, datasets, APIs, and analysis tools covering mouse, human, and non-human primate brain resources.
Annotated Behaviour and Observability Dataset (ABODe)
ABODe is a University of Edinburgh DataShare dataset for behavior classification in group-housed mice using home-cage video, identities, bounding boxes, ground-plate positions, and annotator labels.
DANDI Archive for NWB datasets
DANDI is a BRAIN Initiative archive for publishing and sharing neurophysiology data, including electrophysiology, optophysiology, and behavioral data packaged as NWB and related standards.
International Brain Laboratory public data
The International Brain Laboratory public data releases expose standardized mouse decision-making experiments, including Neuropixels recordings, widefield calcium imaging, behavior, and session metadata accessed through the ONE API.
OpenNeuro
OpenNeuro is a free, open platform for sharing neuroimaging datasets, with public search, dataset pages, and download paths for web, S3, DataLad, and the OpenNeuro CLI.